Cencora, Inc. (COR) Stock Analysis
Last updated Sep 8, 2026
Health Check
Last analyzed Sep 7, 2026
- Financial Health 65
- Profitability 45
- Business Quality 65
- Balance Sheet 55
- Cash Flow 60
Why this rating?
Health 58/100 — Acceptable
Worth tracking, but timing is mixed — not a clear setup yet.
Company overview
Cencora, Inc. (COR) is a Medical Distribution company in the Healthcare sector. Compound Radar rates Cencora, Inc. 58/100 (Acceptable) due to solid business quality, steady revenue growth, and manageable leverage.
Investment profile
- Quality Moderate
- Growth Moderate
- Balance Sheet Adequate
- Valuation Attractive
Financial highlights
Valuation
- P/E 24.1
- Forward P/E 16.42
- PEG 0.69
- EV/Revenue 0.23
Profitability
- Revenue Growth 5.1%
- Gross Margin 4.0%
- Operating Margin 1.4%
- Net Margin 0.8%
- ROE 96.9%
Financial strength
- Cash $2.82B
- Debt $14.46B
- Net Cash $-11.65B
- Free Cash Flow $3.21B
- Current Ratio 0.94
Similar companies
Peers in Medical Distribution, ranked by Financial Health.
Latest quoted price for the name. Helps anchor the setup in today’s market level.
Health Entry- McKesson Corporation Medical Distribution MCK$889.12 63 Health 63 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Henry Schein, Inc. Medical Distribution HSIC$88.86 60 Health 60 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Watch WatchWorth tracking, but timing is mixed — not a clear setup yet.
- Cardinal Health, Inc. Medical Distribution CAH$240.49 55 Health 55 / 100
Solid fundamentals with some trade-offs across our health dimensions.
Wait WaitEntry timing is weak right now. Quality may be fine; the setup is not.
FAQ
How Compound Radar scores and tracks Cencora, Inc. (COR).